We are live on ! Find out more
VM

VV Manager Portfolio holdings

AUM $114M
1-Year Est. Return 59.16%
This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+59.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.5M
AUM Growth
-$37M
Cap. Flow
-$16.1M
Cap. Flow %
-18.24%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$23.5M
2
ALLO icon
Allogene Therapeutics
ALLO
+$14.3M
3
STRO icon
Sutro Biopharma
STRO
+$5.58M

Sector Composition

Rank Sector Weight
1 Healthcare 69.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
1
Allogene Therapeutics
ALLO
$618M
$44.5M 50.32%
2,290,716
-598,935
-21% -$14.3M
QTTB icon
2
Q32 Bio
QTTB
$346M
$12M 13.54%
42,825
– –
STRO icon
3
Sutro Biopharma
STRO
$391M
$4.74M 5.36%
46,486
-53,072
-53% -$5.58M
OYST
4
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
– –
-963,468
Closed -$23.5M

Similar funds

MCM
Maxim Capital Management San Francisco, California $112M AUM 0.1% 1-Year Est. Return
GTP
Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return
APG
Andrew P. Goldfarb $102M AUM 9.91% 1-Year Est. Return
LM
Legg Mason Baltimore, Maryland $127M AUM 6.76% 1-Year Est. Return
VPMV
Venrock Partners Management V Palo Alto, California $101M AUM
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
BWM
Bernicke Wealth Management Altoona, Wisconsin $135M AUM 4.61% 1-Year Est. Return

VV Manager's Q1 2020 Portfolio in Review

As of Q1 2020, VV Manager held 5 positions worth $88.5M, down 29% from $126M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

VV Manager withdrew a net $16.1M in Q1 2020, closing 1 position and reducing 2 holdings. Its most notable exit was Oyster Point Pharma, Inc. Common Stock, an estimated $23.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 100% a quarter earlier.

  • VV Manager's biggest Q1 2020 reduction was Allogene Therapeutics, cutting an estimated $14.3M.
  • VV Manager fully exited Oyster Point Pharma, Inc. Common Stock in Q1 2020, selling an estimated $23.5M.
  • VV Manager's ten largest holdings make up 100% of its $88.5M portfolio in Q1 2020.
  • VV Manager opened 1 new position and closed 1 in Q1 2020.
  • VV Manager's portfolio value fell 29% quarter-over-quarter to $88.5M.

Based on VV Manager's 13F filing for Q1 2020, filed 10 Apr 2020.